Back

Characterizing premature myocardial infarction: clinical, lipid, and behavioral insights from the FRENCHIE Cohort

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Atypical coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Johanne Silvain

Sorbonne University, Paris (France)

5 More presentations in this session

Presentation thumbnail
Long-term interval surveillance of kawasaki disease and associated coronary artery lesions using advanced coronary imaging
Doctor F. Tseng (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of angiographically determined diffuse phenotype in functionally non-significant coronary stenosis
Doctor H. Kirigaya (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic effect of prediabetes defined by different criteria in patients with moderate-to-severe coronary artery calcification: a prospective cohort study
Doctor E. Xie (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes in patients with coronary artery spasm according to first responsive dose of intracoronary acetylcholine
Doctor M. Susanti (Jawa Timur, ID)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular dysfunction endotypes and clinical outcomes in patients with ischemia and no obstructive coronary arteries: A meta-analysis
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Atypical coronary syndromes
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with premature acute myocardial infarction
thumbnail
Congress Presentation
Prognostic factors in young patients with ST-elevation myocardial infarction
thumbnail
Congress Presentation
Phenotyping coronary plaque by computed tomography in premature coronary artery disease.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources